Tag: IgAN

FDA Grants Traditional Approval to First Complement Inhibitor for Primary IgA Nephropathy

The US FDA has granted traditional approval to Novartis' Fabhaltaยฎ (iptacopan), the…

ME Desk

Novartis’ Fabhalta gets FDA nod for IgAN Treatment

Basel- August 2024- Novartis announced that the U.S. Food and Drug Administration…

ME Desk